Eduardo Díaz‐Rubio
0000-0003-2792-5348
Publication & Citation Trends
Publications
571 total
ESMO consensus guidelines for the management of patients with metastatic colorectal cancer PDF
Cited by 3,403
OpenAlex
Prognosis of patients with peritoneal metastatic colorectal cancer given systemic therapy: an analysis of individual patient data from prospective randomised trials from the Analysis and Research in Cancers of the Digestive System (ARCAD) database
Cited by 636
OpenAlex
Clinical validity of circulating tumour cells in patients with metastatic breast cancer: a pooled analysis of individual patient data
Cited by 833
OpenAlex
Bevacizumab in Combination With Oxaliplatin-Based Chemotherapy As First-Line Therapy in Metastatic Colorectal Cancer: A Randomized Phase III Study PDF
Cited by 2,959
OpenAlex
Randomized Phase III Study of Capecitabine Plus Oxaliplatin Compared With Fluorouracil/Folinic Acid Plus Oxaliplatin As First-Line Therapy for Metastatic Colorectal Cancer PDF
Cited by 863
OpenAlex
Open-Label, Uncontrolled, Multicenter Phase II Study to Evaluate the Efficacy and Toxicity of Cetuximab As a Single Agent in Patients With Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck Who Failed to Respond to Platinum-Based Therapy PDF
Cited by 998
OpenAlex
Research Topics
Colorectal Cancer Treatments and Studies
(195)
Cancer Treatment and Pharmacology
(113)
Genetic factors in colorectal cancer
(95)
Gastric Cancer Management and Outcomes
(75)
Cancer Genomics and Diagnostics
(65)
Affiliations
Goethe University Frankfurt
Roche (Switzerland)
Inner Mongolia Agricultural University
Universidad Complutense de Madrid
Oslo University Hospital